Moderator
Elizabeth Molsen-David, RN, ISPOR, Lawrenceville, NJ, United States
Speakers
Onyeka Illoh, MPH, PhD, U.S. FDA, Silver Spring, MD, United States; Jens Grueger, PhD, Boston Consulting Group, Freiburg, Germany; Louis Matza, PhD, Thermo Fisher Scientific, Bethesda, MD, United States; Dan Ollendorf, MPH, PhD, Institute for Clinical and Economic Review (ICER), Boston, MA, United States
ISPOR Task Forces develop expert consensus guidance reports on international good practice standards for the field of HEOR. They set the global benchmark for HEOR through highly cited Good Practices Reports that shape how evidence informs policy, access, and value.
This dynamic session will highlight a new wave of upcoming ISPOR Task Force Reports. Together, they illustrate how these reports address emerging challenges in evidence generation. The following reports will be presented:
- Designing and Implementing Real World Patient Reported Outcomes (RW- PROs) - Emerging Recommendations
- Applying HEOR Methods in Value-Based Healthcare Implementation
- Valuing Child and Adolescent Health States to Derive Utilities for Use in Economic Evaluation
- Methods for Evaluation of Surrogate Endpoints for HTA Decision Making
Join us to gain exclusive insight into the international standards shaping the future of HEOR and discover how ISPOR Good Practices Reports are driving real-world impact across healthcare systems globally.
Topic
Economic Evaluation, Methodological & Statistical Research, Patient-Centered Research